Sign in

CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010382980
Phone
2078782770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-03-11 Rhodes Linda Director Returned to the company −1,009 $6.32 $6K 6,148
2016-01-29 ROTHSCHILD JONATHAN E Director Purchase +4,761 $5.25 $25K 505,397
2016-01-29 ROTHSCHILD JONATHAN E Director Purchase +4,761 $5.25 $25K 510,158
2016-01-29 Tomsche David Scott Director Purchase +6,666 $5.25 $35K 65,834
2016-01-29 Rhodes Linda Director Purchase +2,857 $5.25 $15K 7,157
2016-01-29 Cunningham David Director Purchase +1,904 $5.25 $10K 7,404
2015-12-16 Brockmann Bobbi Jo VP of Sales & Marketing Grant or award · Incentive Stock Option (Right to buy) +10,000 $7.54 $75K 10,000
2015-11-11 ROTHSCHILD JONATHAN E Director Purchase −24,000 500,636
2015-09-14 Wainman Paul R Director Purchase +175 $6.80 $1K 2,000

Page 11 of 11 · 209 trades